Correlation Between China SXT and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both China SXT and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Aquestive Therapeutics, you can compare the effects of market volatilities on China SXT and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Aquestive Therapeutics.
Diversification Opportunities for China SXT and Aquestive Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between China and Aquestive is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of China SXT i.e., China SXT and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between China SXT and Aquestive Therapeutics
Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to under-perform the Aquestive Therapeutics. In addition to that, China SXT is 1.04 times more volatile than Aquestive Therapeutics. It trades about -0.31 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 549.00 in Aquestive Therapeutics on September 1, 2024 and sell it today you would lose (40.00) from holding Aquestive Therapeutics or give up 7.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
China SXT Pharmaceuticals vs. Aquestive Therapeutics
Performance |
| Timeline |
| China SXT Pharmaceuticals |
| Aquestive Therapeutics |
China SXT and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with China SXT and Aquestive Therapeutics
The main advantage of trading using opposite China SXT and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| China SXT vs. Akanda Corp | China SXT vs. Petros Pharmaceuticals | China SXT vs. GelStat Corp | China SXT vs. Shuttle Pharmaceuticals |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |